BioCryst Pharmaceuticals, Inc. (BCRX)
8.17
+0.05
(+0.62%)
USD |
NASDAQ |
Oct 02, 16:00
8.15
-0.02
(-0.24%)
After-Hours: 20:00
BioCryst Pharmaceuticals Market Cap : 2.086B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.086B |
| October 01, 2026 | 2.073B |
| September 30, 2026 | 2.126B |
| September 29, 2026 | 2.111B |
| September 28, 2026 | 2.162B |
| September 25, 2026 | 2.193B |
| September 24, 2026 | 2.175B |
| September 23, 2026 | 2.188B |
| September 22, 2026 | 2.241B |
| September 21, 2026 | 2.236B |
| September 18, 2026 | 2.216B |
| September 17, 2026 | 2.221B |
| September 16, 2026 | 2.152B |
| September 15, 2026 | 2.083B |
| September 14, 2026 | 2.101B |
| September 11, 2026 | 2.073B |
| September 10, 2026 | 2.116B |
| September 09, 2026 | 2.248B |
| September 08, 2026 | 2.314B |
| September 04, 2026 | 2.542B |
| September 03, 2026 | 2.576B |
| September 02, 2026 | 2.596B |
| September 01, 2026 | 2.532B |
| August 31, 2026 | 2.476B |
| August 28, 2026 | 2.507B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.519B |
| August 26, 2026 | 2.509B |
| August 25, 2026 | 2.509B |
| August 24, 2026 | 2.471B |
| August 21, 2026 | 2.438B |
| August 20, 2026 | 2.466B |
| August 19, 2026 | 2.571B |
| August 18, 2026 | 2.476B |
| August 17, 2026 | 2.537B |
| August 14, 2026 | 2.486B |
| August 13, 2026 | 2.504B |
| August 12, 2026 | 2.703B |
| August 11, 2026 | 2.639B |
| August 10, 2026 | 2.512B |
| August 07, 2026 | 2.394B |
| August 06, 2026 | 2.374B |
| August 05, 2026 | 2.315B |
| August 04, 2026 | 2.302B |
| August 03, 2026 | 2.249B |
| July 31, 2026 | 2.281B |
| July 30, 2026 | 2.347B |
| July 29, 2026 | 2.421B |
| July 28, 2026 | 2.474B |
| July 27, 2026 | 2.433B |
| July 24, 2026 | 2.372B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 217.88B |
| Halozyme Therapeutics, Inc. | 12.53B |
| Neurocrine Biosciences, Inc. | 14.55B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
| Agenus, Inc. | 356.27M |
Market Cap Related Metrics
| PS Ratio | 2.055 |
| PEG Ratio | -0.0071 |
| Price to Free Cash Flow | 5.427 |
| Price | 8.17 |
| Earnings Yield | -18.41% |
| PEGY Ratio | -0.0071 |
| Operating PE Ratio | 5.027 |
| Normalized PE Ratio | 14.63 |